Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Buy
62
AJG Quote, Financials, Valuation and Earnings
Last price:
$347.56
Seasonality move
:
3.27%
Day range:
$341.00 - $348.30
52-week range:
$250.51 - $350.70
Dividend yield:
0.71%
P/E ratio:
53.45x
P/S ratio:
6.77x
P/B ratio:
3.99x
Volume:
2.5M
Avg. volume:
1.3M
1-year change:
39.48%
Market cap:
$89B
Revenue:
$11.6B
EPS (TTM):
$6.50
Analysts' Opinion
-
Consensus RatingArthur J. Gallagher & has received a consensus rating of Hold. The company's average rating is a Hold based on 6 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $337.45, Arthur J. Gallagher & has an estimated downside of -2.88% from its current price of $347.44.
-
Price Target UpsideAccording to analysts, the highest upside price target is $388.00 representing -100% upside increase from its current price of $347.44.
Fair Value
-
According to the consensus of 13 analysts, Arthur J. Gallagher & has -2.88% downside to fair value with a price target of $337.45 per share.
AJG vs. S&P 500
-
Over the past 5 trading days, Arthur J. Gallagher & has overperformed the S&P 500 by 1.66% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Arthur J. Gallagher & does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Arthur J. Gallagher & has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Arthur J. Gallagher & reported revenues of $3.7B.
Earnings Growth
-
Arthur J. Gallagher & earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Arthur J. Gallagher & reported earnings per share of $2.72.
Enterprise value:
85.4B
EV / Invested capital:
--
Price / LTM sales:
6.77x
EV / EBIT:
35.29x
EV / Revenue:
7.10x
PEG ratio (5yr expected):
1.69x
EV / Free cash flow:
33.82x
Price / Operating cash flow:
32.25x
Enterprise value / EBITDA:
25.82x
Gross Profit (TTM):
$5.2B
Return On Assets:
2.44%
Net Income Margin (TTM):
12.96%
Return On Equity:
10.03%
Return On Invested Capital:
6.05%
Operating Margin:
28.09%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $8.8B | $10.6B | $12B | $3.3B | $3.7B | |
| Gross Profit | $3.8B | $4.5B | $5.2B | $1.5B | $1.8B | |
| Operating Income | $1.8B | $2B | $2.5B | $848.8M | $1B | |
| EBITDA | $2.3B | $2.4B | $3.3B | $1.1B | $1.3B | |
| Diluted EPS | $5.39 | $4.94 | $6.50 | $2.74 | $2.72 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $12.7B | $27.5B | $28.8B | $41.5B | $53.4B | |
| Total Assets | $24.4B | $43.2B | $45.1B | $61B | $74.1B | |
| Current Liabilities | $11.5B | $26.1B | $27.1B | $39.6B | $37B | |
| Total Liabilities | $17.6B | $34.1B | $35.2B | $49.6B | $51.7B | |
| Total Equity | $6.8B | $9B | $9.9B | $11.3B | $22.4B | |
| Total Debt | $4.5B | $6.2B | $6.9B | $8.3B | $13.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.6B | $2.4B | $2.7B | $789.3M | $871.8M | |
| Cash From Investing | -$1.2B | -$3.2B | -$1.7B | -$191.9M | -$275.4M | |
| Cash From Financing | $1.2B | $1.9B | $14.2B | -$5.4M | $1.1B | |
| Free Cash Flow | $1.4B | $2.2B | $2.5B | $759.6M | $843.6M | |
AJG
Sector
Market Cap
$89B
$608.2M
Price % of 52-Week High
99.07%
87%
Dividend Yield
0.71%
2.03%
Shareholder Yield
-11.52%
4.07%
1-Year Price Total Return
39.48%
10.08%
Beta (5-Year)
0.777
0.587
Dividend yield:
0.71%
Annualized payout:
$2.40
Payout ratio:
35.97%
Growth streak:
14 years
Technicals
8-day SMA
Buy
Level
$340.41
200-day SMA
Buy
Level
$306.41
Bollinger Bands (100)
Buy
Level
304.05 - 341.49
Chaikin Money Flow
Buy
Level
295.5M
20-day SMA
Buy
Level
$338.08
Relative Strength Index (RSI14)
Buy
Level
60.85
ADX Line
Buy
Level
12.35
Williams %R
Sell
Level
-3.7769
50-day SMA
Buy
Level
$333.59
MACD (12, 26)
Buy
Level
3.33
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Neutral
Level
359.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6477)
Sell
CA Score
(Annual)
Level (-1.282)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.5384)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Founded in 1927 as a one-person agency, Gallagher’s primary business is insurance brokerage, with a focus on serving middle-market companies. The company’s risk management segment provides third-party claims adjustment to companies that choose to self-insure. Gallagher has about 56,000 employees and generates about a third of its revenue internationally, primarily in Australia, Canada, New Zealand, and the UK.
Stock Forecast FAQ
In the current month, AJG has received 6 Buy ratings 7 Hold ratings, and 0 Sell ratings. The AJG average analyst price target in the past 3 months is $337.45.
-
Where Will Arthur J. Gallagher & Stock Be In 1 Year?
According to analysts, the consensus estimate is that Arthur J. Gallagher & share price will drop to $337.45 per share over the next 12 months.
-
What Do Analysts Say About Arthur J. Gallagher &?
Analysts are divided on their view about Arthur J. Gallagher & share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Arthur J. Gallagher & is a Sell and believe this share price will rise from its current level to $267.00.
-
What Is Arthur J. Gallagher &'s Price Target?
The price target for Arthur J. Gallagher & over the next 1-year time period is forecast to be $337.45 according to 13 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is AJG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Arthur J. Gallagher & is a Hold. 7 of 13 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of AJG?
You can purchase shares of Arthur J. Gallagher & via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Arthur J. Gallagher & shares.
-
What Is The Arthur J. Gallagher & Share Price Today?
Arthur J. Gallagher & was last trading at $347.56 per share. This represents the most recent stock quote for Arthur J. Gallagher &. Yesterday, Arthur J. Gallagher & closed at $347.44 per share.
-
How To Buy Arthur J. Gallagher & Stock Online?
In order to purchase Arthur J. Gallagher & stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
